Cutaneous findings in patients with acromegaly and its relationship with concomitant endocrinopathies.
acromegaly
cherry angioma
endocrinopathy
skin
skin tag
Journal
Clinical endocrinology
ISSN: 1365-2265
Titre abrégé: Clin Endocrinol (Oxf)
Pays: England
ID NLM: 0346653
Informations de publication
Date de publication:
07 May 2024
07 May 2024
Historique:
revised:
22
04
2024
received:
23
01
2024
accepted:
27
04
2024
medline:
7
5
2024
pubmed:
7
5
2024
entrez:
7
5
2024
Statut:
aheadofprint
Résumé
Skin changes in acromegaly are often the first sign of the disease. The aim of this study was to describe the cutaneous findings in patients with acromegaly. In addition, a secondary aim was to investigate the possible association of these findings with remission status and concomitant endocrinopathies. In this prospective multicenter study, 278 patients over the age of 18 years with acromegaly who were followed up in 14 different tertiary healthcare institutions were included. These patients, who were followed up by the Endocrinology Department, were then referred to a dermatologist for dermatological examination. The frequency of skin lesions was investigated by detailed dermatologic examination. Dermatological diagnosis is reached by clinical, dermatological and/or dermoscopic examination, and rarely skin punch biopsy examinations in suspicious cases. The possible association of the skin findings between remitted and nonremitted patients and with concomitant endocrinopathies were evaluated. The most common skin findings in patients with acromegaly in our study were skin tags (52.5%), cherry angiomas (47.4%), seborrhoea (37%), varicose veins (33%), acneiform lesions (28.8%), hyperhidrosis (26.9%) and hypertrichosis (18.3%). Hypertrichosis was significantly more prevalent in patients nonremitted (p: .001), while xerosis cutis was significantly more prevalent in patients remitted (p: .001). The frequency of diabetes mellitus and hypothyroidism was significantly higher in patients with varicose veins and seborrhoeic keratosis than those without. Additionally, the coexistence of hypothyroidism, hyperthyroidism and galactorrhea was significantly higher in patients with Cherry angioma than in those without Cherry angioma (p-values: .024, .034 and .027, respectively). The frequency of hypogonadism in those with xerosis cutis was significantly higher than in those without (p: .035). Cutaneous androgenization findings such as skin tag, seborrhoea, acne and acanthosis nigricans are common in patients with acromegaly. Clinicians should be aware that skin findings associated with insulin resistance may develop in these patients. It can be said that the remission state in acromegaly has no curative effect on cutaneous findings. Only patients in remission were less likely to have hypertrichosis. This may allow earlier review of the follow-up and treatment of acromegaly patients presenting with complaints of hypertrichosis. Additionally, it can be said that patients with skin findings such as cherry angioma may be predisposed to a second endocrinopathy, especially hypothyroidism. Including dermatology in a multidisciplinary perspective in acromegaly patient management would be beneficial to detect cutaneous findings earlier.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Molitch ME. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am. 1992;21:597‐614.
Akoglu G, Metin A, Emre S, Ersoy R, Cakir B. Cutaneous findings in patients with acromegaly. Acta Dermatovenerol Croat. 2013;21:224‐229.
Dahbar M, Danilowicz K, Malavela M, et al. Cutaneous manifestations of acromegaly. Dermatol Argent. 2009;15:186‐190.
Vila G, Jørgensen JOL, Luger A, Stalla GK. Insulin resistance in patients with acromegaly. Front Endocrinol. 2019;10:509.
Centurión SA, Schwartz RA. Cutaneous signs of acromegaly. Int J Dermatol. 2002;41:631‐634.
Nabarro JDN. Acromegaly. Clin Endocrinol. 1987;26:481‐512.
Arya KR, Krishna K, Chadda M. Skin manifestations of acromegaly – a study of 34 cases. Indian J Dermatol Venereol Leprol. 1997;63:178‐180.
Resende M, Bolfi F, Nunes VS, Miot HA. Prevalence of dermatologic disorders in 15 patients with acromegaly. An Bras Dermatol. 2012;87:166‐168.
Cordido F, García Arnés JA, Marazuela Aspiroz M, Torres Vela E. grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición. Guía práctica de diagnóstico y tratamiento de la acromegalia. [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición]. Endocrinol Nutr. 2013;60:457.e1‐457.e15.
Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017;6:300‐312.
Nakashima T, Jinnin M, Etoh T, et al. Down‐regulation of mir‐424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One. 2010;5:e14334.
Ben‐Shlomo A, Melmed S. Skin manifestations in acromegaly. Clin Dermatol. 2006;24:256‐259.
Chalmers RJ, Ead RD, Beck MH, Dewis P, Anderson DC. Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J (Clin Res Ed). 1983;287:1346‐1347.
Sandru F, Popa A, Paduraru D, Filipescu A, Carsote M, Ghemigian A. Skin anomalies in acromegalic patients (review of the practical aspects). Exp Ther Med. 2021;22:1330.
Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853‐876.
Niknam N, Khalili N, Khosravi E, Nourbakhsh M. Endothelial dysfunction in patients with subclinical hypothyroidism and the effects of treatment with levothyroxine. Adv Biomed Res. 2016;5:38.
Lange M, Thulesen J, Feldt‐Rasmussen U, et al. Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol. 2001;145:147‐153.
Jain R, Dutta D, Shivaprasad K, et al. Acromegaly presenting as hirsuitism: uncommon sinister aetiology of a common clinical sign. Indian J Endocrinol Metab. 2012;16:297.
Girisha B, Viswanathan N. Comparison of cutaneous manifestations of diabetic with nondiabetic patients: a case‐control study. Clin Dermatol Rev. 2017;1:9‐14.
Kaltsas GA, Mukherjee JJ, Jenkins PJ, et al. Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab. 1999;84:2731‐2735.
Degirmentepe EN, Gungor S, Kocaturk E, et al. Dermatologic manifestations of acromegaly: a case in point and a focused review. Dermatol Online J. 2017;23:4.
Scheinfeld N. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J. 2013;19:18558.
Todd DJ, Eedy DJ, McMillan JC. Acromegaly and psoriasis. Clin Exp Dermatol. 1991;16:222‐223.
Weber G, Klughardt G, Neidhardt M, Galle K, Frey H, Geiger A. Treatment of psoriasis with somatostatin. Arch Dermatol Res. 1981;272:31‐36.
Zanini M, Oshiro RR, Paschoal LHC, Paschoal FM, Timoner FR. Aspectos dermatológicos da acromegalia. An Bras Dermatol. 2004;79:491‐494.
Billon C, Beylot‐Barry M, Doutre MS, Latapie JL, Roger P, Beylot C. Cutaneous manifestations of acromegaly: 4 cases. Ann Dermatol Venereol. 1996;123:821‐823.